RePaReREGENETEN Bioinductive Implant System for Rotator Cuff Repair: Real World Post-Market Evaluation
This study aims to observe and evaluate the real-world effectiveness of the REGENETEN Bioinductive Implant System in patients who have undergone rotator cuff repair, using measures such as the EuroQol 5 Dimension 5 Level Score, Oxford Shoulder Score, Pain Visual Analog Scale Score, Quick DASH Score, and Single Assessment Numeric Evaluation Score.
Data Collection
Collected from today forward - ProspectiveShoulder Injuries+2
+ Rotator Cuff Injuries
+ Rupture
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: October 1, 2020
Actual date on which the first participant was enrolled.This study focuses on individuals undergoing rotator cuff repair using the REGENETEN◊ Bioinductive Implant System. The main goal is to gather real-world data from up to 400 patients across 50 centers in the UK, Europe, and Australia. The study aims to understand the clinical and health economic outcomes following this specific type of rotator cuff repair. This research is important as it can provide valuable insights into the effectiveness and cost-efficiency of the REGENETEN◊ Bioinductive Implant System in real-world settings, potentially improving care for those with rotator cuff injuries. Patients participating in this study will receive treatment and evaluation according to standard medical care. The study will collect outcome data for up to 2 years post-surgery. The outcomes measured include the EuroQol 5 Dimension 5 Level (EQ-5D-5L) score, Oxford Shoulder Score (OSS), Pain Visual Analog Scale (VAS) score, Quick DASH (Disabilities of Arm, Shoulder and Hand) score, and Single Assessment Numeric Evaluation (SANE) score. These measures assess various aspects of a patient's health and quality of life, such as mobility, self-care, usual activities, pain, and overall shoulder condition. Higher scores in these measures generally indicate better outcomes.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.400 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 19 locations
Burnley General Teaching Hospital
Burnley, United KingdomOpen Burnley General Teaching Hospital in Google MapsManchester University NHS Foundation Trust
Manchester, United KingdomGrantham and District Hospital
Grantham, United KingdomUniversity College London Hospitals
London, United Kingdom